Mad2 overexpression is associated with high cell proliferation and reduced disease-free survival in primary gastrointestinal diffuse large B-cell lymphoma

Increasing Incidence Rates, Distribution and Histological Characteristics of Primary Gastrointestinal Non-Hodgkin Lymphoma in a North American Population

(2016) JM Howell et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Combination analysis of Bub1 and Mad2 expression in endometrial cancer: act as a prognostic factor in endometrial cancer

(2013) Lin Li et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

The recognition and classification of lymphoproliferative disorders of the gut

(2013) Dennis P. O'Malley et al.   HUMAN PATHOLOGY

Catalytic Assembly of the Mitotic Checkpoint Inhibitor BubR1-Cdc20 by a Mad2-Induced Functional Switch in Cdc20

(2013) Joo Seok Han et al.   MOLECULAR CELL

High expression of spindle assembly checkpoint proteins CDC20 and MAD2 is associated with poor prognosis in urothelial bladder cancer

(2013) Jung-Woo Choi et al.   VIRCHOWS ARCHIV

Incidence of lymphoproliferative disorders in patients with celiac disease

(2012) Lori A. Leslie et al.   AMERICAN JOURNAL OF HEMATOLOGY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients

(2011) Tatsuya Kato et al.   LUNG CANCER

Primary gastrointestinal lymphoma

(2011) Prasanna Ghimire   WORLD JOURNAL OF GASTROENTEROLOGY

Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal

(2010) Rocio Sotillo et al.   NATURE

Surgery does not adversely affect survival in primary gastrointestinal lymphoma

(2009) Michael C. Cheung et al.   JOURNAL OF SURGICAL ONCOLOGY

Aberrant MAD2 expression in soft-tissue sarcoma

(2008) Masanori Hisaoka et al.   PATHOLOGY INTERNATIONAL